The present invention relates generally to tissue anchors, and specifically to tissue anchors for implantation in soft tissue, such as cardiac tissue.
Tissue anchors are used for anchoring elements, such as pacemaker electrode leads or sutures, to tissue, such as bone or soft tissue. PCT Publication WO 2016/087934 to Gilmore et al., which is incorporated in its entirety herein by reference, describes a tissue anchor that includes a shaft, a tissue-coupling element, and a flexible elongate tension member. The tissue-coupling element includes a wire, which is shaped as an open loop coil having, in some applications, more than one coil revolution when the tissue anchor is unconstrained, i.e., expanded from a linear state to a coiled state. The tension member includes a distal portion, that is fixed to a site on the open loop coil, a proximal portion, which has a longitudinal segment that runs alongside at least a portion of the shaft, and a crossing portion, which (i) is disposed between the distal and the proximal portions along the tension member, and (ii) crosses at least a portion of the open loop when the tissue anchor is expanded. The tissue anchor is configured to allow relative axial motion between the at least a portion of the shaft and the longitudinal segment of the proximal portion of the tension member when the tissue anchor is expanded.
US Patent Application Publication 2002/0013571 to Goldfarb et al. describes methods and devices for grasping, and optional repositioning and fixation of the valve leaflets to treat cardiac valve regurgitation, particularly mitral valve regurgitation.
Embodiments of the present invention provide an expandable tissue anchor that is deliverable to a cardiac chamber in an unexpanded generally elongate configuration within a deployment tool. The expandable tissue anchor is configured to be anchored to a cardiac tissue wall at a target site such that a tensile force can be applied to the expandable tissue anchor and thus to the cardiac tissue wall, once the expandable tissue anchor is deployed, so as to move the cardiac tissue wall at the target site relative to adjacent cardiac tissue. For some applications, such motion alters the geometry of a cardiac valve, such as the tricuspid valve or the mitral valve.
An expandable tissue anchor is provided configured to be deliverable to a cardiac chamber in an unexpanded generally elongate configuration within a percutaneous deployment tool, where the expandable tissue anchor is configured to be anchored to a cardiac tissue wall at a target site such that a tensile force can be applied to the expandable tissue anchor and thus to the cardiac tissue wall, once the expandable tissue anchor is deployed, so as to move the cardiac tissue wall at the target site relative to adjacent cardiac tissue. In some applications, the expandable tissue anchor comprises (1) an elongate tissue-coupling portion supported by an anchor shaft at a first end of the tissue-coupling portion, where the tissue-coupling portion is configured to be delivered in an unexpanded generally elongate configuration through the cardiac tissue wall from a first side of the wall to a second side of the wall, the tissue-coupling portion is further configured to expand, on the second side of the cardiac tissue wall, to an expanded open shape coil configuration, such that the expanded tissue-coupling portion can be drawn tightly against the second side of the cardiac tissue wall at the target site when the tensile force is applied to the tissue-coupling portion, and where the tissue-coupling portion comprising material having a first stiffness, and (2) an elongate tip portion supported at a second end of the tissue-coupling portion and configured to be delivered through the cardiac tissue wall ahead of the tissue-coupling portion, where the tip portion comprises material having a second stiffness less than the first stiffness.
In some applications, the tissue-coupling portion, once expanded on the second side of the cardiac tissue wall, comprises a configuration generally orthogonal to the anchor shaft. In some applications, the tip portion is configured such that when the cardiac tissue wall is a myocardial tissue wall, the tip portion can be directed, upon deployment in the pericardial cavity on the second side of the myocardial tissue wall, into the pericardial cavity ahead of the tissue-coupling portion, generally alongside and against pericardial tissue surrounding the myocardial tissue wall, without penetrating the pericardial tissue.
The tip portion may be axially fixed with respect to the tissue-coupling portion, or may be integral to the tissue-coupling portion. In some applications, the tip portion comprises a core wire and a coil wire wound around the core wire. In some applications, the tissue-coupling portion comprises a proximal portion and a distal bullet head, which is fixed to a distal end of the proximal portion, and has, at a widest longitudinal site along the bullet head, a greatest outer cross-sectional area that equals at least 150% of an average outer cross-sectional area of the proximal portion, and the bullet head serves as a crimp to secure the coil wire of the tip portion to the tissue-coupling portion.
In some applications, the tissue-coupling portion and the tip portion comprise a hollow tube. In some applications, the first stiffness of the tissue-coupling portion is at least 10% greater than the second stiffness of the tip portion. In some applications, the tip portion has a length of at least 3 mm. In some applications, the tip portion is not axially compressible.
In some applications, the tip portion comprises a plurality of slits that provides the lower stiffness of material than the tissue-coupling portion. In some cases, an average outer diameter of the tip portion is less than an average outer diameter of the tissue-coupling portion so as to provide the lesser lower stiffness of the material of the tip portion.
In some applications, the tip portion comprises a core wire and a coil wire wound around the core wire. In some applications, the tissue-coupling portion comprises a proximal portion and a distal bullet head, which is fixed to a distal end of the proximal portion, and has, at a widest longitudinal site along the bullet head, a greatest outer cross-sectional area that equals at least 150% of an average outer cross-sectional area of the proximal portion, and the bullet head serves as a crimp to secure the tip portion to the tissue-coupling portion.
In some applications, the expandable tissue anchor further comprises an elongate tension member coupled to a portion of the tissue-engaging coupling portion such that the tensile force can be applied to the tissue-coupling portion after it has been expanded to the open shape configuration. In some applications, the tip portion is an integral distal extension of the elongate tension member. In some applications, the tip portion is shaped as a closed loop, with a distal end of the elongate tension member fixed to the tissue-coupling portion near the second end of the tissue-coupling portion. In some applications, the tissue-coupling portion comprises a proximal portion and a distal bullet head, which is fixed to a distal end of the proximal portion, and has, at a widest longitudinal site along the bullet head, a greatest outer cross-sectional area that equals at least 150% of an average outer cross-sectional area of the proximal portion, and the bullet head serves as a crimp to secure the distal end of the elongate tension member to the tissue-coupling portion.
In some applications, an anchor system is provided that comprises the tension member expandable tissue anchor applications contemplated herein, and further comprises a tether affixed to the elongate tension member such that the tensile force can be applied to the expandable tissue anchor via the tether and the elongate tension member. In some applications, the anchor system comprises a second expandable tissue anchor, separate and distinct from the first expandable tissue anchor.
There is further provided, in accordance with an application of the present invention, a method for moving a cardiac tissue wall at a target site relative to adjacent cardiac tissue, the method including:
delivering, to a cardiac chamber, an expandable tissue anchor in an unexpanded generally elongate configuration within a deployment tool, the expandable tissue anchor including (a) an elongate tissue-coupling portion supported by an anchor shaft at a first end of the tissue-coupling portion, and including material having a first stiffness and (b) an elongate tip portion supported at a second end of the tissue-coupling portion, and including material having a second stiffness less than the first stiffness;
delivering the elongate tip portion through the cardiac tissue wall ahead of the tissue-coupling portion;
delivering the tissue-coupling portion in an unexpanded generally elongate configuration through the cardiac tissue wall from a first side of the wall to a second side of the wall, such that the tissue-coupling portion expands, on the second side of the cardiac tissue wall, to an expanded open shape configuration, thereby anchoring the expandable tissue anchor to the cardiac tissue wall at the target site; and
tightly drawing the expanded tissue-coupling portion against the second side of the cardiac tissue wall at the target site by applying a tensile force to the tissue-coupling portion, and thus to the cardiac tissue wall, so as to move the cardiac tissue wall at the target site relative to the adjacent cardiac tissue.
For some applications, the cardiac tissue wall is a myocardial tissue wall, and delivering the tip portion through the cardiac tissue wall ahead of the tissue-coupling portion includes directing the tip portion, upon deployment in the pericardial cavity on the second side of the myocardial tissue wall, into the pericardial cavity ahead of the tissue-coupling portion, generally alongside and against pericardial tissue surrounding the myocardial tissue wall, without penetrating the pericardial tissue.
For some applications, applying a tensile force to the tissue-coupling portion includes applying the tensile force to an elongate tension member coupled to a portion of the tissue-coupling portion. For some applications, applying the tensile force to the elongate tension member includes applying the tensile force to a tether affixed to the elongate tension member.
For some applications, the method further includes implanting a second expandable tissue anchor, separate and distinct from the expandable tissue anchor.
The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
Referring to
Expandable tissue anchor 20 further comprises an elongate tip portion 38 supported at a second end 40 of tissue-coupling portion 30 and configured to be delivered through the cardiac tissue wall ahead of tissue-coupling portion 30, such as described hereinbelow with reference to
For some applications, tissue-coupling portion 30, once expanded on the second side of the cardiac tissue wall, such as described hereinbelow with reference to
Referring to
Referring to
Reference is still made to
Referring to
Referring to
In some configurations, elongate tissue-coupling portion 230 comprises a narrow proximal portion 236 and a distal bullet head 222 (shown in cross section in
Bullet head 222 may increase the surface area of tissue-coupling portion 230 for pressing against myocardial tissue wall 60, described hereinbelow with reference to
Referring to
For some applications, tip portion 338 comprises core wire 356 and a coil wire 354 wound around core wire 356. Core wire 356 may, for example, comprise Nitinol, and coil wire 354 may, for example, comprise a platinum-iridium alloy, and is typically radiopaque, such as for visualization under fluoroscopy.
In some configurations, elongate tissue-coupling portion 330 comprises a narrow proximal portion 336 and a distal bullet head 322 (shown in cross section in
Bullet head 322 may increase the surface area of tissue-coupling portion 330 for pressing against myocardial tissue wall 60, described hereinbelow with reference to
Optionally, tissue anchor 320 further comprises an elongate tension member 346, similar to elongate tension member 46 described hereinabove with reference to
Referring to
For some applications, elongate tissue-coupling portion 430 comprises a narrow proximal portion 436, and tip portion 438 comprises core wire 456 that is an integral distal extension of proximal portion 436 of tissue-coupling portion 430. Proximal portion 436 narrows at a tapering portion 458 to provide narrower core wire 456, as described above.
For some applications, tip portion 438 further comprises a coil wire 454 wound around core wire 456. Core wire 456 may, for example, comprise Nitinol, and coil wire 454 may, for example, comprise a platinum-iridium alloy, and is typically radiopaque.
In some configurations, elongate tissue-coupling portion 430 further comprises a distal bullet head 422 (shown in cross section in
Bullet head 422 may increase the surface area of tissue-coupling portion 430 for pressing against myocardial tissue wall 60, described hereinbelow with reference to
Optionally, tissue anchor 420 further comprises an elongate tension member 446, similar to elongate tension member 46 described hereinabove with reference to
For some applications, tip portion 438 has a length L, distally beyond second end 440 of tissue-coupling portion 430, of at least 3 mm, such as at least 5 mm, or even at least 20 mm (but typically no more than 60 mm), which may additionally provide a clear indication of pericardial placement. (Tip portion 438 of tissue anchor 320, described hereinabove with reference to
Referring to
Still referring to
Reference is now made to
As shown in
As shown in
As shown in
Once expandable tissue anchor 20 has been anchored to myocardial tissue wall 60 at the target site, a tensile force is applied using tether 52 to expandable tissue anchor 20 and thus to myocardial tissue wall 60, so as to move myocardial tissue wall 60 at the target site relative to adjacent cardiac tissue. For some applications, such motion can have the benefit of altering the geometry of a nearby cardiac valve, such as the tricuspid valve or the mitral valve.
The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. For some applications, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein: U.S. Pat. No. 8,475,525 to Maisano et al.; U.S. Pat. No. 8,961,596 to Maisano et al.; U.S. Pat. No. 8,961,594 to Maisano et al.; PCT Publication WO 2011/089601; U.S. Pat. No. 9,241,702 to Maisano et al.; PCT Publication WO 2013/011502; U.S. Provisional Application 61/750,427, filed Jan. 9, 2013; U.S. Provisional Application 61/783,224, filed Mar. 14, 2013; PCT Publication WO 2013/179295; U.S. Provisional Application 61/897,491, filed Oct. 30, 2013; U.S. Provisional Application 61/897,509, filed Oct. 30, 2013; U.S. Pat. No. 9,307,980 to Gilmore et al.; PCT Publication WO 2014/108903; PCT Publication WO 2014/141239; U.S. Provisional Application 62/014,397, filed Jun. 19, 2014; PCT Publication WO 2015/063580; US Patent Application Publication 2015/0119936; U.S. Provisional Application 62/086,269, filed Dec. 2, 2014; U.S. Provisional Application 62/131,636, filed Mar. 11, 2015; U.S. Provisional Application 62/167,660, filed May 28, 2015; PCT Publication WO 2015/193728; PCT Publication WO 2016/087934; US Patent Application Publication 2016/0242762; PCT Publication WO 2016/189391; and US Patent Application Publication 2016/0262741.
Patents and patent application publications incorporated by reference in the present patent application are to be considered an integral part of the application except that to the extent any terms are defined in these incorporated patents and patent application publications in a manner that conflicts with the definitions made explicitly or implicitly in the present specification, only the definitions in the present specification should be considered.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application claims priority from (a) International Application PCT/IL2017/050771, filed Jul. 10, 2017, and (b) U.S. Provisional Application 62/376,685, filed Aug. 18, 2016, which are assigned to the assignee of the present application and are incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2017/047442 | 8/17/2017 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62376685 | Aug 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/IL2017/050771 | Jul 2017 | US |
Child | 16326332 | US |